T. Kawamura

发表

Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study

H. Sawada, A. Umemura, T. Oeda, 2013, BMC Neurology.

Methylphenylpyridium ion (MPP+) enhances glutamate‐induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon

S. Shimohama, H. Sawada, J. Kimura, 1996, Journal of neuroscience research.

Endogenously Occurring β‐Carboline Induces Parkinsonism in Nonprimate Animals: A Possible Causative Protoxin in Idiopathic Parkinson's Disease

H. Sawada, A. Akaike, K. Matsubara, 1998 .

Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease

S. Shimohama, H. Sawada, M. Ohba, 2009, European journal of neurology.

Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial

K. Hisanaga, H. Sawada, Mitsutoshi Yamamoto, 2010, PloS one.

Effect of ghrelin on the motor deficit caused by the ablation of nigrostriatal dopaminergic cells or the inhibition of striatal dopamine receptors.

A. Yamanaka, M. Shibasaki, N. Kuzumaki, 2018, Biochemical and biophysical research communications.

Cocaine and phenylephrine eye drop test for Parkinson disease.

S. Shimohama, H. Sawada, M. Ohba, 2005, Journal of the American Medical Association (JAMA).

Different mechanisms of glutamate‐induced neuronal death between dopaminergic and non‐dopaminergic neurons in rat mesencephalic culture

S Shimohama, H Sawada, A Akaike, 1996, Journal of neuroscience research.

Endogenously occurring beta-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease.

H. Sawada, A. Akaike, K. Matsubara, 1998, Journal of neurochemistry.

Mechanism of resistance to NO‐induced neurotoxicity in cultured rat dopaminergic neurons

Y. Kitamura, T. Taniguchi, S. Shimohama, 1996, Journal of neuroscience research.